A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis

Cell

Volumn 137, Issue 6, 2009, Pages 1032-1046

  Valastyan, Scott ^a,b   Reinhardt, Ferenc ^a   Benaich, Nathan ^a,c   Calogrias, Diana ^d   Szász, Attila M ^d   Wang, Zhigang C ^d,e   Brock, Jane E ^d   Richardson, Andrea L ^d   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c WILLIAMS COLLEGE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

CELLBIO; HUMDISEASE; RNA

Indexed keywords

MICRORNA; MICRORNA 31; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INVASION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL;

EID: 66449095667     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.03.047     Document Type: Article

References (40)

1. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., and Allgayer H. MicroRNA-21 post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27 (2008) 2128-2136
2. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25 (2000) 25-29
3. Aslakson C.J., and Miller F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52 (1992) 1399-1405
4. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 136 (2009) 215-233
5. Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.F., Dunning M.J., Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8 (2007) R214
6. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
7. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101 (2004) 2999-3004
8. Desmedt C., Haibe-Kains B., Wirapati P., Buyse M., Larsimont D., Bontempi G., Delorenzi M., Piccart M., and Sotiriou C. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin. Cancer Res. 14 (2008) 5158-5165
9. Ebert M.S., Neilson J.R., and Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4 (2007) 721-726
10. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3 (2003) 453-458
11. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., and Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27 (2007) 91-105
12. Gupta G.P., and Massagué J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
13. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 10 (2008) 202-210
14. Hüsemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmüller G., et al. Systemic spread is an early step in breast cancer. Cancer Cell 13 (2008) 58-68
15. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005) 7065-7070
16. Kondo N., Toyama T., Sugiura H., Fujii Y., and Yamashita H. miR-206 expression is down-regulated in estrogen receptor α-positive human breast cancer. Cancer Res. 68 (2008) 5004-5008
17. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., et al. Combinatorial microRNA target predictions. Nat. Genet. 37 (2005) 495-500
18. Krützfeldt J., Poy M.N., and Stoffel M. Strategies to determine the biological function of microRNAs. Nat. Genet. 38 (2006) S14-S19
19. Lujambio A., Calin G.A., Villanueva A., Ropero S., Sánchez-Céspedes M., Blanco D., Montuenga L.M., Rossi S., Nicoloso M.S., Faller W.J., et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. USA 105 (2008) 13556-13561
20. Ma L., Teruya-Feldstein J., and Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007) 682-688
21. Massagué J. TGFβ in cancer. Cell 134 (2008) 215-230
22. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., Fedele V., Ginzinger D., Getts R., and Haqq C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 19 (2006) 5-24
23. McClatchey A.I. Merlin and ERM proteins: unappreciated roles in cancer development?. Nat. Rev. Cancer 3 (2003) 877-883
24. Minn A.J., Kang Y., Serganova I., Gupta G.P., Giri D.D., Doubrovin M., Ponomarev V., Gerald W.L., Blasberg R., and Massagué J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115 (2005) 44-55
25. Morris V.L., Tuck A.B., Wilson S.M., Percy D., and Chambers A.F. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines. Clin. Exp. Metastasis 11 (1993) 103-112
26. Sahai E., and Marshall C.J. Rho-GTPases and cancer. Nat. Rev. Cancer 2 (2002) 133-142
27. Sanchez-Carbayo M., Socci N.D., Lozano J., Saint F., and Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24 (2006) 778-789
28. Sathyan P., Golden H.B., and Miranda R.C. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure. J. Neurosci. 27 (2007) 8546-8557
29. Si M.L., Zhu S., Wu H., Lu Z., Wu F., and Mo Y.Y. miR-21-mediated tumor growth. Oncogene 26 (2007) 2799-2803
30. Silahtaroglu A.N., Nolting D., Dyrskjøt L., Berezikov E., Møller M., Tommerup N., and Kauppinen S. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using LNA probes and tyramide signal amplification. Nat. Protocols 2 (2007) 2520-2528
31. Sørlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98 (2001) 10869-10874
32. Steeg P.S. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer 3 (2003) 55-63
33. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., and Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (2008) 147-152
34. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 (2002) 1999-2009
35. Ventura A., and Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 136 (2009) 586-591
36. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103 (2006) 2257-2261
37. Voorhoeve P.M., le Sage C., Schrier M., Gillis A.J., Stoop H., Nagel R., Liu Y.P., van Duijse J., Drost J., Griekspoor A., et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 (2006) 1169-1181
38. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X., and Shao J.Y. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 (2008) 2348-2360
39. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., Liang S., Naylor T.L., Barchetti A., Ward M.R., et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. USA 103 (2006) 9136-9141
40. Zhu S., Wu H., Wu F., Nie D., Sheng S., and Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18 (2008) 350-359